References & Citations For Too Much, Too Little: The Testosterone Balancing Act (For All Genders)
-
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., ... & Witchel, S. F. (2006). Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome. The Journal of Clinical Endocrinology & Metabolism, 91(11), 4237-4245.
-
Bagatell, C. J., & Bremner, W. J. (1996). Androgens in men—uses and abuses. New England Journal of Medicine, 334(11), 707-714.
-
Basson, R., Brotto, L. A., Petkau, A. J., & Labrie, F. (2000). Role of androgens in women's sexual dysfunction. Menopause, 17(5), 962–971.
-
Bhasin, S., Woodhouse, L., & Storer, T. W. (2001). Proof of the effect of testosterone on skeletal muscle. Journal of Endocrinology, 170(1), 27–38.
-
Bhasin, S., Cunningham, G. R., Hayes, F. J., et al. (2010). Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 95(6), 2536-2559.
-
Björkhem, I. (1996). Sex hormones and acne. Dermatology, 193(4), 242–245.
-
Cistulli, P. A., Grunstein, R. R., & Sullivan, C. E. (1994). Sleep apnoea and testosterone levels in men. Thorax, 49(6), 621–622.
-
Corona, G., Mannucci, E., Forti, G., & Maggi, M. (2014). Hypogonadism and erectile dysfunction: when to treat with testosterone? Nature Reviews Urology, 9(7), 425–433.
-
Davison, S. L., Bell, R., Donath, S., Montalto, J. G., & Davis, S. R. (2005). Androgen levels in adult females: changes with age, menopause, and oophorectomy. Journal of Clinical Endocrinology & Metabolism, 90(7), 3847–3853.
-
Dunaif, A. (1997). Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews, 18(6), 774–800.
-
Glaser, R. L., & Dimitrakakis, C. (2013). Testosterone therapy in women: myths and misconceptions. Maturitas, 74(3), 230–234.
-
Grossmann, M., & Wu, F. C. W. (2014). Male obesity and the role of sex steroids. Asian Journal of Andrology, 16(2), 133–138.
-
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001). Longitudinal effects of aging on serum total and free testosterone levels in healthy men. The Journal of Clinical Endocrinology & Metabolism, 86(2), 724–731.
-
Kingsberg, S. A., Clayton, A. H., & Pfaus, J. G. (2010). The female sexual response: a different model. Journal of Sex & Marital Therapy, 36(4), 339–352.
-
Khosla, S., Amin, S., & Orwoll, E. (2008). Osteoporosis in men. Endocrine Reviews, 29(4), 441–464.
-
Lucky, A. W., Biro, F. M., Huster, G. A., & Morrison, J. A. (1997). Acne and hormones. Dermatologic Clinics, 15(1), 15–23.
-
NHS. (2023). Polycystic Ovary Syndrome (PCOS). [online] Available at: https://www.nhs.uk/conditions/polycystic-ovary-syndrome-pcos/
-
Pope, H. G., Kouri, E. M., & Hudson, J. I. (2000). Effects of supraphysiologic doses of testosterone on mood and aggression in normal men. Archives of General Psychiatry, 57(2), 133–140.
-
Sambrook, P., & Cooper, C. (2006). Osteoporosis. Lancet, 367(9527), 2010–2018.
-
Tan, R. S., & Scally, M. C. (2009). Anabolic steroid-induced hypogonadism—towards a unified hypothesis of anabolic steroid action. Medical Hypotheses, 72(6), 723–728.
-
Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., & Rosner, W. (2010). Androgen therapy in women: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 95(6), 2536–2559.
-
Wu, F. C., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., ... & Huhtaniemi, I. T. (2008). Identification of late-onset hypogonadism in middle-aged and elderly men. New England Journal of Medicine, 363(2), 123–135.
-
Yildiz, B. O., Knochenhauer, E. S., & Azziz, R. (2010). Impact of obesity on the risk for polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism, 93(1), 162–168.
-
Akdogan, M., Tamer, M. N., Cure, E., Cure, M. C., Bahçeci, M., & Onur, I. (2007). Effect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutism. Phytotherapy Research, 21(5), 444–447.
-
Cumming, D. C., Quigley, M. E., & Yen, S. S. (1983). Acute suppression of circulating testosterone levels by cortisol in men. The Journal of Clinical Endocrinology & Metabolism, 57(3), 671–673.
-
Diamanti-Kandarakis, E., & Dunaif, A. (2012). Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Reviews, 33(6), 981–1030.
-
Grant, P. (2010). Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. Phytotherapy Research, 24(2), 186–188.
-
Hayes, L. D., Grace, F. M., Sculthorpe, N., & Herbert, P. (2015). Exercise-induced responses in salivary testosterone, cortisol and their ratios in men: a meta-analysis. Sports Medicine, 45(5), 713–726.
-
Kraemer, W. J., Ratamess, N. A., & French, D. N. (2002). Resistance training for health and performance. Current Sports Medicine Reports, 1(3), 165–171.
-
Leproult, R., & Van Cauter, E. (2011). Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA, 305(21), 2173–2174.
-
Moran, L. J., Noakes, M., Clifton, P. M., Wittert, G. A., & Norman, R. J. (2003). Short-term meal replacements followed by dietary protein supplementation enhance weight loss in polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 88(12), 5696–5702.
-
Pilz, S., Frisch, S., Koertke, H., Kuhn, J., Dreier, J., Obermayer-Pietsch, B., Wehr, E., Zittermann, A., & Berthold, H. K. (2011). Effect of vitamin D supplementation on testosterone levels in men. Hormone and Metabolic Research, 43(3), 223–225.
-
Sturgeon, S. R., Ronnenberg, A. G., & Demissie, K. (1999). Lignans, phytoestrogens, and hormone-related cancers. Annals of the New York Academy of Sciences, 889(1), 244–255.
-
Tan, R. S., & Scally, M. C. (2009). Anabolic steroid-induced hypogonadism—towards a unified hypothesis of anabolic steroid action. Medical Hypotheses, 72(6), 723–728.
-
Wang, C., Jackson, G., Jones, T. H., Matsumoto, A. M., Nehra, A., Perelman, M. A., & Swerdloff, R. S. (2004). Low testosterone associated with obesity and the metabolic syndrome. Mayo Clinic Proceedings, 79(6), 707–713.


